theMednetRegister
  • Community
    • Overview
    • Experts
    • Editors
    • Fellows
    • Code of conduct
    • AI Guidelines for Physicians
  • Company
    • About Us
    • FAQs
    • Privacy Policy
    • Terms of Use
    • Careers
    • Programs
  • News
    • News Releases
    • Press Coverage
    • Publications
    • Blog
  • Contact Us
  • Sign in

Neurology

ITP   

Questions discussed in this category


Would you offer TPO-RAs to a steroid-refractory chronic ITP patient with history of stroke?
Is the thrombotic risk associated with TPO-RAs only relevant to VTE or does it also apply to arterial thromboses and stroke? Can the risk be mitigated...
1 Answer available
25895


Papers discussed in this category


British journal of haematology, 2019-05
Romiplostim in adult patients with newly diagnosed or persistent immune thrombocytopenia (ITP) for up to 1 year and in those with chronic ITP for more than 1 year: a subgroup analysis of integrated data from completed romiplostim studies.

Blood Adv, 2019 Dec 10
American Society of Hematology 2019 guidelines for immune thrombocytopenia.

Related Topics in Neurology

  • Breast Cancer
  • Head and Neck Cancers
  • Hematologic Malignancies
  • Radiation Oncology
  • Gynecologic Oncology
  • Palliation
  • Neuro-Oncology
  • Gastrointestinal Cancers
  • Non-malignant Disease
  • Pediatric Hematology/Oncology

Copyright © 2025 theMednet
All Rights Reserved.